Bufalin induces mitochondria-dependent apoptosis in pancreatic and oral cancer cells by downregulating hTERT expression via activation of the JNK/p38 pathway

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Tian, Xin ^a   Dai, Shundong ^a,b   Sun, Jing ^c   Jiang, Shenyi ^a   Sui, Chengguang ^a   Meng, Fandong ^a   Li, Yan ^a   Fu, Liye ^a   Jiang, Tao ^a   Wang, Yang ^a   Su, Jia ^a   Jiang, Youhong ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Institute of Pathology and Pathophysiology   (China)

^c LIAONING CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BUFALIN; CASPASE 3; CASPASE 9; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; TELOMERASE REVERSE TRANSCRIPTASE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IC50; MITOCHONDRION; ORAL CANCER CELL LINE; PANCREATIC CANCER CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84953286613     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/546210     Document Type: Article

References (31)

1. L. Krenn and B. Kopp, Bufadienolides from animal and plant sources, Phytochemistry, vol. 48, no. 1, pp. 1-29, 1998.
2. Y. Jing, M. Watabe, S. Hashimoto, S. Nakajo, and K. Nakaya, Cell cycle arrest and protein kinasemodulating effect of bufalin on human leukemiaML1 cells, Anticancer Research, vol. 14, no. 3, pp. 1193-1198, 1994.
3. Z. Zhu, E. Li, Y. Liu et al., Bufalin induces the apoptosis of acute promyelocytic leukemia cells via the downregulation of survivin expression, Acta Haematologica, vol. 128, no. 3, pp. 144-150, 2012.
4. K.-Q. Han, G. Huang, W. Gu, Y.-H. Su, X.-Q. Huang, and C.-Q. Ling, Anti-tumor activities and apoptosis-regulated mechanisms of bufalin on the orthotopic transplantation tumor model of human hepatocellular carcinoma in nude mice, World Journal of Gastroenterology, vol. 13, no. 24, pp. 3374-3379, 2007.
5. Z.-J. Zhang, Y.-K. Yang, and W.-Z. Wu, Bufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude mice, Journal of Translational Medicine, vol. 12, article 57, 2014.
6. D. Li, X. Qu, K. Hou et al., PI3K/Akt is involved in bufalininduced apoptosis in gastric cancer cells, Anti-Cancer Drugs, vol. 20, no. 1, pp. 59-64, 2009.
7. P. Yin, B. Liang, X. Guo et al., Preparation of bufalin-loaded pluronic polyetherimide nanoparticles, cellular uptake, distribution, and effect on colorectal cancer, International Journal of Nanomedicine, vol. 9, no. 1, pp. 4035-4041, 2014.
8. S. Yan, X. Qu, L. Xu et al., Bufalin enhances TRAIL-induced apoptosis by redistributing death receptors in lipid rafts in breast cancer cells, Anti-Cancer Drugs, vol. 25, no. 6, pp. 683-689, 2014.
9. W. Gu, L. Liu, F.-F. Fang, F. Huang, B.-B. Cheng, and B. Li, Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells, Oncology Reports, vol. 31, no. 1, pp. 216-222, 2014.
10. P.-H. Yin, X. Liu, Y.-Y. Qiu et al., Anti-tumor activity and apoptosis-regulationmechanisms of bufalin in various cancers: new hope for cancer patients, Asian Pacific Journal of Cancer Prevention, vol. 13, no. 11, pp. 5339-5343, 2012.
11. S. H. Hong, G.-Y. Kim, Y.-C. Chang, S.-K. Moon, W.-J. Kim, and Y. H. Choi, Bufalin prevents the migration and invasion of T24 bladder carcinoma cells through the inactivation of matrix metalloproteinases and modulation of tight junctions, International Journal of Oncology, vol. 42, no. 1, pp. 277-286, 2013.
12. Y.-Y. Chen, H.-F. Lu, S.-C. Hsu et al., Bufalin inhibits migration and invasion in human hepatocellular carcinoma SK-Hep1 cells through the inhibitions of NF-kB and matrix metalloproteinase-2/-9-signaling pathways, Environmental Toxicology, vol. 30, no. 1, pp. 74-82, 2015.
13. L. Sun, T. Chen, X. Wang, Y. Chen, and X. Wei, Bufalin induces reactive oxygen species dependent Bax translocation and apoptosis in ASTC-a-1 cells, Evidence-Based Complementary and AlternativeMedicine, vol. 2011, Article ID249090, 12 pages, 2011.
14. D. Wang and Z. Bi, Bufalin inhibited the growth of human osteosarcoma MG-63 cells via down-regulation of Bcl-2/Bax and triggering of the mitochondrial pathway, Tumor Biology, vol. 35, no. 5, pp. 4885-4890, 2014.
15. D.-W. Ding, Y.-H. Zhang, X.-E. Huang, Q. An, and X. Zhang, Bufalin induces mitochondrial pathway-mediated apoptosis in lung adenocarcinoma cells, Asian Pacific Journal of Cancer Prevention, vol. 15, no. 23, pp. 10495-10500, 2014.
16. M. P. Rubtsova, D. P. Vasilkova, A. N. Malyavko, Y. V. Naraikina, M. I. Zvereva, and O. A. Dontsova, Telomere lengthening and other functions of telomerase, Acta Naturae, vol. 4, no. 2, pp. 44-61, 2012.
17. J. W. Shay and S. Bacchetti, A survey of telomerase activity in human cancer, European Journal of Cancer Part A, vol. 33, no. 5, pp. 787-791, 1997.
18. Y. S. Cong, W. E. Wright, and J. W. Shay, Humantelomerase and its regulation,Microbiology andMolecular Biology Reviews, vol. 66, no. 3, pp. 407-425, 2002.
19. S. Kyo, M. Takakura, T. Fujiwara, and M. Inoue, Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers, Cancer Science, vol. 99, no. 8, pp. 1528-1538, 2008.
20. Y. Cong and J. W. Shay, Actions of human telomerase beyond telomeres, Cell Research, vol. 18, no. 7, pp. 725-732, 2008.
21. J. H. Santos, J. N. Meyer, and B. Van Houten, Mitochondrial localization of telomerase as a determinant for hydrogen peroxide-induced mitochondrial DNA damage and apoptosis, Human Molecular Genetics, vol. 15, no. 11, pp. 1757-1768, 2006.
22. I. R. Indran, M. P. Hande, and S. Pervaiz, hTERT overexpression alleviates intracellular ROS production, improves mitochondrial function, and inhibits ROS-mediated apoptosis in cancer cells, Cancer Research, vol. 71, no. 1, pp. 266-276, 2011.
23. J. Haendeler, S. Drose, N. Buchner et al., Mitochondrial telomerase reverse transcriptase binds to and protects mitochondrial DNA and function from damage, Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 6, pp. 929-935, 2009.
24. E. Lamy, V. Goetz, M. Erlacher, C. Herz, and V. Mersch-Sundermann, HTERT: another brick in the wall of cancer cells, Mutation Research: Reviews in Mutation Research, vol. 752, no. 2, pp. 119-128, 2013.
25. S. Pervaiz and M.-V. Clement, Hydrogen peroxide-induced apoptosis: oxidative or reductive stress? in Methods in Enzymology, vol. 352, chapter 13, pp. 150-159, Elsevier, 2002.
26. L.-H. Yih and T.-C. Lee, Arsenite induces p53 accumulation through an ATM-dependent pathway in human fibroblasts, Cancer Research, vol. 60, no. 22, pp. 6346-6352, 2000.
27. S.-C. Tsai, C.-C. Lu, C.-Y. Lee et al., AKT serine/threonine protein kinase modulates bufalin-triggered intrinsic pathway of apoptosis in CAL 27 human oral cancer cells, International Journal of Oncology, vol. 41, no. 5, pp. 1683-1692, 2012.
28. M. Li, X. Yu, H. Guo et al., Bufalin exerts antitumor effects by inducing cell cycle arrest and triggering apoptosis in pancreatic cancer cells, Tumor Biology, vol. 35, no. 3, pp. 2461-2471, 2014.
29. X.-B. Xie, L.-L. Wen, J.-Q. Yin et al., Proteomics research of bufalin-induced apoptosis in osteosarcoma cell lines, Zhongguo Zhongyao Zazhi, vol. 39, no. 14, pp. 2739-2743, 2014.
30. X. Tian, H. Yin, S. Zhang et al., Bufalin loaded biotinylated chitosan nanoparticles: an efficient drug delivery system for targeted chemotherapy against breast carcinoma, European Journal of Pharmaceutics and Biopharmaceutics, vol. 87, no. 3, pp. 445-453, 2014.
31. Y. Li, J. Yuan, Q. Yang et al., Immunoliposome co-delivery of bufalin and anti-CD40 antibody adjuvant induces synergetic therapeutic efficacy against melanoma, International Journal of Nanomedicine, vol. 9, no. 1, pp. 5683-5700, 2014.